Please enable JS

DISCOVER

ToTem4me

Success is when the time to access an innovative treatment is reduced.

ToTem4me is a multi-device application aiming at facilitating the recruitment of patients in clinical studies.

It assists the patients in detecting the studies close to their home for which they are potentially eligible according to their current health conditions.

Access ToTem4me

WHAT IS
ToTem4me?

A web app, with a high visibility as it is accessible on the AFA (the patient association in IBD in France) website.

A powerful algorithm, adapted with and for patients (Based on CT-SCCOUT™ technology & know-how).

“Live” support for the patients from a highly trained expert to identify the appropriate study in a convenient location.

LATEST NEWSOUR NEWS >

telemedecine technologies news

Standards in Sync: Accelerating Medical Research – EUCROF Webinar

June 27, 2024

25 September 2024 from 4:00PM to 5:30PM (CEST) Webinar Overview It has been demonstrated that using standards from the start of clinical research studies (i.e. protocol and CRF development) can save significant time and resources and results in higher quality research. Unfortunately, it is not always clear how to select the appropriate standards for the […]

READ MORE
telemedecine technologies news

Addressing Data Management Challenges With Automation

June 27, 2024

Applied Clinical Trials Online ACT: How can data management challenges be addressed? Specifically, is there any opportunity to address them with artificial intelligence (AI)? Lacroix: There is a lot of opportunity across the life cycle to assist with this and it’s interesting because historically it was always: we want to throw people at some of […]

READ MORE
telemedecine technologies news

Why early market access planning is crucial in CGT commercial strategy

June 27, 2024

Fiercebiotech Experts recommend that CGT manufacturers proactively design a comprehensive market access strategy early in clinical development and commercial planning timelines, ideally more than three years prior to launch. This strategy should focus on addressing the nuanced market access challenges for such treatments, including but not limited to, distribution network design, tailored commercial site engagement, […]

READ MORE